Can diabetic retinopathy worsen during pregnancy? New research questions trimester-specific risks and highlights the value of personalized eye screening.
Read More »A New DME Drug Matched Anti-VEGF on Vision: Could Retina Care Be Ready for a New Option?
Discover how remigromig performed against anti-VEGF therapy in the BRUNELLO trial and what AAO 2026 findings mean for diabetic macular edema care.
Read More »Could Fenofibrate Slow Diabetic Eye Disease in Type 1 Diabetes?
Can fenofibrate slow diabetic retinopathy in type 1 diabetes? Explore new LENS trial research, potential benefits, safety, and clinical implications.
Read More »Quit Smoking, Protect More Than Your Heart: When Diabetes Complication Risk Starts to Fall
New research links smoking cessation to lower diabetes complication risks. Explore what the findings mean for kidney, eye, and nerve health.
Read More »GLP-1s and Vision Loss: What Prescribers Should Know About the Emerging NAION Signal
GLP-1 receptor agonists have transformed type 2 diabetes and obesity treatment, but a rare vision safety signal deserves clinicians’ attention. Emerging evidence has raised concerns about a potential NAION risk with GLP-1 therapy, particularly with semaglutide (Ozempic, Rybelsus, and Wegovy). Non-arteritic anterior ischemic optic neuropathy (NAION) can cause sudden, usually …
Read More »Your Eye Exam May Be Predicting More Than Vision Loss: AI Is Finding Hidden Diabetes Risks
For people with diabetes, a retinal photograph has traditionally answered one major question: Is diabetic retinopathy developing? However, artificial intelligence is beginning to uncover much more. Emerging retinal AI models for systemic risk assessment can detect patterns associated with cardiovascular disease, kidney disease, blood pressure, and metabolic health. As a …
Read More »Diabetic Eye Disease May Start Years Before Your Eye Exam Finds It
Diabetes affects far more than blood sugar. In fact, the earliest stages of diabetic retinal disease may begin years before an eye doctor can see the classic signs of diabetic retinopathy during a routine examination. Imagine a smoke detector that alerts you before you ever see flames. That is the …
Read More »A Newly Discovered Form of Cell Death May Explain Why Diabetes Causes So Many Complications
Diabetes is known for raising blood sugar levels, but its long-term complications often have the greatest impact on health. Kidney disease, vision loss, nerve damage, and cardiovascular disease affect millions of people living with diabetes. For years, researchers focused on inflammation, oxidative stress, and poor circulation to explain these complications. …
Read More »Can AI Eye Exams Expand Diabetic Retinopathy Screening Access?
Diabetic retinopathy remains one of the leading causes of preventable blindness worldwide. Yet despite clear screening guidelines, many patients with diabetes still miss their annual retinal exams. Busy schedules, limited specialist access, transportation barriers, and lack of awareness often delay diagnosis until vision changes become permanent. As healthcare systems search …
Read More »GLP-1s and Rapid A1C Reduction: Should We Be Monitoring Retinopathy More Closely?
GLP-1 receptor agonists and dual incretin therapies are transforming diabetes care. These medications often produce significant and rapid improvements in glycemic control, sometimes lowering A1C levels faster than traditional treatments. However, clinicians have begun asking an important question: could rapid A1C reduction with GLP-1 therapy increase retinopathy risk in some …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.